CHS takes controlling stake in SMG

Beng Teck Liang, chief executive officer of Singapore Medical Group

Analysts remain positive on Singapore Medical Group after Korea’s CHA Health Systems takes a controlling stake in the private specialist healthcare provider. “We are very excited by the partnership of both groups,” said Robert Allen, CHS global chief executive officer “CHS has a strong reputation for world-class fertility treatments, pioneering many of the cutting-edge advances…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »